154 related articles for article (PubMed ID: 20299956)
1. Conjugate and polysaccharide pneumococcal vaccines do not improve initial response of the polysaccharide vaccine in HIV-infected adults.
Peñaranda M; Payeras A; Cambra A; Mila J; Riera M;
AIDS; 2010 May; 24(8):1226-8. PubMed ID: 20299956
[TBL] [Abstract][Full Text] [Related]
2. Conjugate pneumococcal vaccine in HIV-infected Ugandans and the effect of past receipt of polysaccharide vaccine.
Miiro G; Kayhty H; Watera C; Tolmie H; Whitworth JA; Gilks CF; French N
J Infect Dis; 2005 Nov; 192(10):1801-5. PubMed ID: 16235180
[TBL] [Abstract][Full Text] [Related]
3. Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults.
Lesprit P; Pédrono G; Molina JM; Goujard C; Girard PM; Sarrazin N; Katlama C; Yéni P; Morineau P; Delfraissy JF; Chêne G; Lévy Y;
AIDS; 2007 Nov; 21(18):2425-34. PubMed ID: 18025879
[TBL] [Abstract][Full Text] [Related]
4. Induction of opsonophagocytic killing activity with pneumococcal conjugate vaccine in human immunodeficiency virus-infected Ugandan adults.
Chen M; Ssali F; Mulungi M; Awio P; Yoshimine H; Kuroki R; Furumoto A; Tanimura S; Kityo C; Nagatake T; Mugyenyi P; Oishi K
Vaccine; 2008 Sep; 26(38):4962-8. PubMed ID: 18639599
[TBL] [Abstract][Full Text] [Related]
5. Improving the immunogenicity of pneumococcal conjugate vaccine in HIV-infected adults with a toll-like receptor 9 agonist adjuvant: a randomized, controlled trial.
Søgaard OS; Lohse N; Harboe ZB; Offersen R; Bukh AR; Davis HL; Schønheyder HC; Østergaard L
Clin Infect Dis; 2010 Jul; 51(1):42-50. PubMed ID: 20504165
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.
Abzug MJ; Pelton SI; Song LY; Fenton T; Levin MJ; Nachman SA; Borkowsky W; Rosenblatt HM; Marcinak JF; Dieudonne A; Abrams EJ; Pathak I;
Pediatr Infect Dis J; 2006 Oct; 25(10):920-9. PubMed ID: 17006288
[TBL] [Abstract][Full Text] [Related]
7. The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50-80 years.
Goldblatt D; Southern J; Andrews N; Ashton L; Burbidge P; Woodgate S; Pebody R; Miller E
Clin Infect Dis; 2009 Nov; 49(9):1318-25. PubMed ID: 19814624
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449
[TBL] [Abstract][Full Text] [Related]
9. Opsonic function of bronchoalveolar lavage IgG after pneumococcal vaccination in HIV-infected and uninfected adults.
Tam JC; Grant NL; Freire-Moran L; Tolmie H; French N; Gordon SB
J Allergy Clin Immunol; 2009 Jun; 123(6):1420-1. PubMed ID: 19423153
[No Abstract] [Full Text] [Related]
10. Immunogenicity of sequential pneumococcal vaccination in subjects splenectomised for hereditary spherocytosis.
Stoehr GA; Rose MA; Eber SW; Heidemann K; Schubert R; Zielen S
Br J Haematol; 2006 Mar; 132(6):788-90. PubMed ID: 16487181
[TBL] [Abstract][Full Text] [Related]
11. Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine.
Madhi SA; Adrian P; Kuwanda L; Jassat W; Jones S; Little T; Soininen A; Cutland C; Klugman KP
Vaccine; 2007 Mar; 25(13):2451-7. PubMed ID: 17023095
[TBL] [Abstract][Full Text] [Related]
12. Comparison of serologic responses to vaccination with one dose or two doses of 7-valent pneumococcal conjugate vaccine in HIV-infected adult patients.
Lu CL; Hung CC; Chuang YC; Liu WC; Su CT; Hsiao CF; Tseng YT; Su YC; Chang SF; Chang SY; Chang SC
Vaccine; 2012 May; 30(24):3526-33. PubMed ID: 22484349
[TBL] [Abstract][Full Text] [Related]
13. Serological response to pneumococcal vaccination in HAART-treated HIV-infected patients: one year follow-up study.
Falcó V; Jordano Q; Cruz MJ; Len O; Ribera E; Campins M; Crespo M; Ocaña I; Rodrigo MJ; Pahissa A
Vaccine; 2006 Mar; 24(14):2567-74. PubMed ID: 16423429
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults.
Kroon FP; van Dissel JT; Ravensbergen E; Nibbering PH; van Furth R
Vaccine; 2000 Nov; 19(7-8):886-94. PubMed ID: 11115712
[TBL] [Abstract][Full Text] [Related]
15. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
[TBL] [Abstract][Full Text] [Related]
16. Randomised, controlled trial of concomitant pneumococcal and meningococcal conjugate vaccines.
Wysocki J; Tansey S; Brachet E; Baker S; Gruber W; Giardina P; Arora A
Vaccine; 2010 Nov; 28(49):7779-86. PubMed ID: 20883736
[TBL] [Abstract][Full Text] [Related]
17. Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant.
Wuorimaa T; Dagan R; Väkeväinen M; Bailleux F; Haikala R; Yaich M; Eskola J; Käyhty H
J Infect Dis; 2001 Nov; 184(9):1211-5. PubMed ID: 11598848
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
19. The potential role for protein-conjugate pneumococcal vaccine in adults: what is the supporting evidence?
Musher DM; Sampath R; Rodriguez-Barradas MC
Clin Infect Dis; 2011 Mar; 52(5):633-40. PubMed ID: 21292668
[TBL] [Abstract][Full Text] [Related]
20. A case-control study to investigate serological correlates of clinical failure of 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults.
French N; Moore M; Haikala R; Kayhty H; Gilks CF
J Infect Dis; 2004 Aug; 190(4):707-12. PubMed ID: 15272398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
